Searched for: author:"Dankert-Roelse, J.E."
(1 - 12 of 12)
document
Dankert-Roelse, J.E. (author), Bouvs, M.J. (author), Jakobs, B.S. (author), Janssens, H.M. (author), de Winter-de Groot, K.M. (author), Schonbeck, Y. (author), Gille, J.J.P. (author), Gulmans, V.A.M. (author), Verschoof-Puite, R.K. (author), Schielen, P.C.J.I. (author), Verkerk, P.H. (author)
Background Newborn screening for cystic fibrosis (NBSCF) was introduced in the Dutch NBS program in 2011 with a novel strategy. Methods Dutch NBSCF consisted of four steps: immuno-reactive trypsin (IRT), Pancreatitis-associated Protein (PAP), DNA analysis by Inno-LiPa (35 mutations), extended gene analysis (EGA) as fourth step and as safety net....
article 2019
document
van der Ploeg, C.P.B. (author), van den Akker-van Marle, M.E. (author), Vernooij-van Langen, A.M.M. (author), Elvers, L.H. (author), Gille, J.J.P. (author), Verkerk, P.H. (author), Dankert-Roelse, J.E. (author), Loeber, J.G. (author), Triepels, R.H. (author), van der Pal, S.M. (author), Dompeling, E. (author), Pals, G. (author), Gulmans, V.A.M. (author), Oey-Spauwen, M.J.W. (author), Wijnands, Y.H.H.M. (author), Castricum, L.M. (author), Arets, H.G.M. (author), van der Ent, C.K. (author), Tiddens, H.A.W.M. (author), de Rijke, Y.B. (author), Yntema, J.B. (author)
BACKGROUND: Previous cost-effectiveness studies using data from the literature showed that newborn screening for cystic fibrosis (NBSCF) is a good economic option with positive health effects and longer survival. METHODS: We used primary data to compare cost-effectiveness of four screening strategies for NBSCF, i.e. immunoreactive trypsinogen...
article 2015
document
Vernooij-van Langen, A.M.M. (author), van der Pal, S.M. (author), Reijntjens, A.J.T. (author), Loeber, J.G. (author), Dompeling, E. (author), Dankert-Roelse, J.E. (author)
Background: False-positive screening results in newborn screening for cystic fibrosis may lead to parental stress, family relationship problems and a changed perception of the child's health. Aim of the study: To evaluate whether parental anxiety induced by a false positive screening result disappears after six months and to assess whether a...
article 2014
document
Vernooij-van Langen, A.M.M. (author), Reijntjes, S. (author), van der Pal, S.M. (author), Loeber, G.J. (author), Dompeling, E. (author), Dankert-Roelse, J.E. (author)
article 2013
document
Vernooij-van Langen, A.M.M. (author), Reijntjens, S. (author), van der Pal, S.M. (author), Loeber, J.G. (author), Dompeling, E. (author), Dankert-Roelse, J.E. (author)
Purpose: Most newborn screening (NBS) strategies for Cystic Fibrosis (CF) also identify carriers. However, it is unclear if parents want to be informed about their child's carrier status or not. Methods: Focus group discussions with pregnant couples to explore their opinions about disclosure of a carrier result for CF of their newborn. Results:...
article 2013
document
Vernooij-Van Langen, A.M.M. (author), Loeber, J.G. (author), Elvers, B. (author), Triepels, R.H. (author), Gille, J.J.P. (author), van der Ploeg, C.P.B. (author), Reijntjens, S. (author), Dompeling, E. (author), Dankert-Roelse, J.E. (author)
Context: Newborn screening for cystic fibrosis (CF) is included in many routine programmes but current strategies have considerable drawbacks, such as false-positive tests, equivocal diagnosis and detection of carriers. Objective: To assess the test performance of two newborn screening strategies for CF. Design, setting and participants: In 2008...
article 2012
document
Vernooij-Van Langen, A.M.M. (author), Loeber, J.G. (author), van der Ploeg, C.P.B. (author), Dompeling, E. (author), Dankert-Roelse, J.E. (author)
article 2012
document
Vernooij-van Langen, A.M.M. (author), Reijntjens, S. (author), van der Pal, S.M. (author), Loeber, J.G. (author), Dompeling, E. (author), Dankert-Roelse, J.E. (author)
article 2011
document
Vernooij-van Langen, A.M.M. (author), Loeber, J.G. (author), Elvers, L.H. (author), Triepels, R.H. (author), Gille, J.J.P. (author), van der Ploeg, C.P.B. (author), Reijntjes, A.J.T. (author), Dompeling, E. (author), Dankert-Roelse, J.E. (author), TNO Kwaliteit van Leven (author)
Abstract of the 32nd European Cystic Fibrosis Conference.
article 2009
document
Dankert-Roelse, J.E. (author), Vernooij-van Langen, A.M.M. (author), Loeber, J.G. (author), Elvers, L.H. (author), Triepels, R.H. (author), Gille, J.J.P. (author), Pals, G. (author), van den Akker-van Marle, M.E. (author), van der Ploeg, C.P.B. (author), van der Pal, S.M. (author), Gulmans, V.A.M. (author), Oey-Spauwen, M.J.W. (author), Wijnands, Y.H.H.M. (author), Bosch, M. (author), Dompeling, E. (author), Reijntjes, A.J.T. (author), TNO Kwaliteit van Leven (author)
book 2009
document
van den Akker-van Marle, M.E. (author), Verkerk, P.H. (author), Dankert-Roelse, J.E. (author), TNO Kwaliteit van Leven (author)
article 2008
document
van den Akker-van Marle, M.E. (author), Dankert, H.M. (author), Verkerk, P.H. (author), Dankert-Roelse, J.E. (author), TNO Kwaliteit van Leven (author)
OBJECTIVES. The purpose of this work was to assess the costs of 4 neonatal screening strategies for cystic fibrosis in relation to health effects. In each strategy, the first test was the measurement of serum concentration of immunoreactive trypsin. The second step consisted of either a second immunoreactive trypsin test (strategy 1) or a...
article 2006
Searched for: author:"Dankert-Roelse, J.E."
(1 - 12 of 12)